(HealthDay)—In liver transplantation (LT), patients who receive living donor grafts from first-degree relatives due to autoimmune liver diseases are not prone to increased disease recurrence, compared to those who receive ...
Apr 25, 2016
0
3
Depression may compound the risk of developing type 2 diabetes in people with such early warning signs of metabolic disease as obesity, high blood pressure and unhealthy cholesterol levels, according to researchers from McGill ...
Apr 12, 2016
1
58
A high ratio of two types of immune system cell is linked to an increased risk of disease recurrence after a diagnosis of early stage breast cancer, finds the first study of its kind, published on the eve of international ...
Mar 7, 2016
0
12
Patients who received chemotherapy after surgical resection of pancreatic cancer have fewer distant disease recurrences and longer overall survival than those who also had adjuvant chemoradiation therapy. While a course of ...
Feb 17, 2016
0
7
(HealthDay)—For patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma (HPV+ OPSCC), most of the disease recurrence and late toxicity events after treatment occur within six months, according ...
Feb 15, 2016
0
2
Newly published research from a National Cancer Institute-funded randomized trial shows that women who were provided with skills to manage stress early in their breast cancer treatment show greater length of survival and ...
Dec 1, 2015
0
2
Based on the results of EORTC trial 18071, the FDA expanded the approval of Yervoy (ipilimumab) in melanoma to include adjuvant treatment of patients with stage 3 melanoma at high risk of recurrence following complete resection.
Nov 13, 2015
0
4
Oropharyngeal cancer patients who were found to have detectable traces of human papillomavirus type 16 (HPV16) in their saliva following cancer treatment are at an increased risk for recurrence, a study led by researchers ...
Jul 30, 2015
0
21
Results of an EORTC trial appearing in The Lancet Oncology show that adjuvant Ipilimumab significantly improves recurrence-free survival in patients with completely resected stage III melanoma at high risk of disease recurrence, ...
Apr 20, 2015
0
3
Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression.
Apr 15, 2015
0
16
